Ash Wallington: Why Are We Throwing Away 97% of the Cure?
Ash Wallington, Executive Director in Stanford Technology Ventures Program at Stanford University, shared a post on LinkedIn:
“Why are we throwing away 97% of the cure?
When I was 29 weeks pregnant, I decided to donate my baby’s cord blood instead of it being treated as medical waste.
You need to register before week 32.
Easy right?
No.
Instead I hit upon a frustrating systemic failure, countless forms and poor infrastructural support to complete the donation.
Fortunately, last week I delivered a healthy baby boy, and within a few hours we sent the cord blood off with a courier, hoping it can make a difference in research or treatment for someone out there.
The numbers are staggering:
- 97% of all cord blood in the US (rich in life-saving stem cells) is discarded as medical waste
- Of the 3% that is actually captured, about 90% is stored in private banks for individual use, where it may never be used. See all the sponsored ads attached.
That leaves only about 0.3% of this total biological ‘gold’ available for public donation to save a stranger’s life.
Why this is a tragedy of ‘Medical Resource Management’: We talk about bone marrow and regular blood donation as the gold standards of giving, but cord blood is in a category of its own!
More than 80 illnesses: Cord blood stem cells are currently used to treat over 80 life-threatening diseases, including leukemia, lymphoma, and sickle cell anemia.
The ‘Universal’ Advantage: Unlike bone marrow, which requires a near-perfect genetic match (a ‘Grand Challenge’ for multi-ethnic patients), cord blood is ‘immunologically immature.’ It doesn’t require a perfect match to be successful, making it the most viable option for patients who can’t find a marrow donor.
Zero Risk, One Opportunity: Unlike bone marrow (which requires surgery or intense procedures) or blood (which you can give every 8 weeks), cord blood donation is painless, non-invasive, and happens only once per birth. It’s a literal one-shot opportunity to harvest ‘biological gold’ before it gets tossed in the bin.
The systemic problem:
- The SEO Gap: Private, lucrative business models spend millions to dominate search results, while public donation infrastructure is underfunded and invisible. Such. A. Shame.
- The Infrastructure Gap: Public banks are so under-resourced that even a motivated donor can’t get a return call or an email back (I’m still waiting, UC Davis).
- The Logistical Moat: If you don’t deliver at a specific ‘partner hospital,’ the system effectively tells you your donation isn’t worth the transport cost.
We talk about ‘healthcare innovation,’ but we are failing at basic resource recovery. We have the ‘Grand Challenge’ of treating leukemia, sickle cell anemia, and more than 80 other diseases, yet we allow the primary resource to be thrown in the trash.
If you’re in the healthcare, policy, or tech space, how do we fix this?
How do we make the ‘right choice’ the ‘easy choice’ for parents?”
Stay updated with Hemostasis Today.
-
Jun 26, 2026, 18:28Daniel Pereira Monteiro: Why Is Beta Thalassaemia Major so Severe?
-
Jun 26, 2026, 18:27Pradip Pawar: Cell and Gene Therapy – Transforming Medicine in the 21st Century
-
Jun 26, 2026, 18:26Aviva Schwartz: How Can We Better Protect Patients After an Ischemic Stroke?
-
Jun 26, 2026, 18:25Does Reversing Factor Xa Inhibitors Really Carry as Much Thrombotic Risk as We Think? – RPTH Journal
-
Jun 26, 2026, 18:25Akshat Jain: Novel Therapies in Childhood Blood and Cancer Disorders
-
Jun 26, 2026, 16:57Abdul Muqtadir Abbasi: Anticoagulation in DVT Patients With Hidden Varices Requires Extreme Caution
-
Jun 26, 2026, 16:42Anesa Mulabecirovic: Why Von Willebrand Disease Takes Years to Diagnose in Women
-
Jun 26, 2026, 16:32Kaitlin Lichty: A New Identity Reflecting a Shared Legacy of Bleeding Disorders
-
Jun 26, 2026, 16:07Toong Youttananukorn: The WFH Registry Driving Better Care and Advocacy